title: Is it safe to use erythropoiesis-stimulating agents to treat anemia in chronic kidney disease patients with active malignancies?
authors.affiliation: Division of Nephrology, Department of Internal Medicine, Johns Hopkins University, Baltimore, Maryland 21205, USA.
authors.forename: Gaurav
authors.initials: G
authors.lastname: Gupta
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Choi
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D002908:Chronic Disease; D006397:Hematinics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D009369:Neoplasms / Q000150:complications
chemical_list: D006397:Hematinics